Affiliation:
1. Laboratory of Radiation Biology, Joint Institute for Nuclear Research, Dubna, Russian Federation
Abstract
Background:
Cells have specific enzymes (nucleoside triphosphate pyrophosphohydrolase)
that hydrolyze non-canonic nucleoside triphosphates into nucleoside monophosphophates and pyrophosphate,
thus removing them from the metabolic processes. This class of enzymes includes inosine
triphosphate pyrophosphatase (ITPA) which has specificity to ITP, dITP, XTP and dXTP.
Objective:
The mutation (94C→A) rather often occurs in humans and can affect the sensitivity of patients
to medicines. This mutation leads to a Pro32Thr substitution in the human ITPA protein. The
mechanism for the inactivating effect of the mutation is unknown yet.
Methods:
Molecular modeling of the polymorphic form of inosine triphosphate pyrophosphohydrolase
Р32Т-hITPA showing the greatest decrease in the enzyme activity is performed. The analysis is
given for four dimer variants: wild-type (P32/P32) and mutant (T32/T32) homodimers and two mutant
heterodimers (Р32/Т32 and Т32/Р32).
Results:
The analysis does not show the motion of the loop between α2 and β2 where mutation localized.
Thus, the hypothesis of the flipped-out hydrophobic residue and subsequent of protein degradation
have not been confirmed. Dimer displacements were much higher than subunit displacements.
The analysis of hydrogen bonds between subunits shows that there are the more stable hydrogen
bonds in the wild-type homodimer and fewer in the mutant homodimer, while heterodimers have intermediate
stability.
Conclusion:
The results confirm the assumption of possible weakening of bonds between the mutant
subunits
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Molecular Medicine,Biochemistry